Vanguard Group’s Jazz Pharmaceuticals JAZZ Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $646M | Buy |
6,090,872
+73,469
| +1% | +$7.8M | 0.01% | 880 |
|
|
2025
Q1 | $747M | Sell |
6,017,403
-18,780
| -0.3% | -$2.33M | 0.01% | 789 |
|
|
2024
Q4 | $743M | Sell |
6,036,183
-71,326
| -1% | -$8.78M | 0.01% | 817 |
|
|
2024
Q3 | $680M | Sell |
6,107,509
-215,199
| -3% | -$24M | 0.01% | 859 |
|
|
2024
Q2 | $675M | Sell |
6,322,708
-125,981
| -2% | -$13.4M | 0.01% | 815 |
|
|
2024
Q1 | $777M | Buy |
6,448,689
+84,941
| +1% | +$10.2M | 0.02% | 763 |
|
|
2023
Q4 | $783M | Sell |
6,363,748
-15,305
| -0.2% | -$1.88M | 0.02% | 724 |
|
|
2023
Q3 | $826M | Buy |
6,379,053
+29,960
| +0.5% | +$3.88M | 0.02% | 655 |
|
|
2023
Q2 | $787M | Buy |
6,349,093
+174,029
| +3% | +$21.6M | 0.02% | 688 |
|
|
2023
Q1 | $904M | Buy |
6,175,064
+124,439
| +2% | +$18.2M | 0.02% | 635 |
|
|
2022
Q4 | $964M | Buy |
6,050,625
+161,859
| +3% | +$25.8M | 0.03% | 591 |
|
|
2022
Q3 | $785M | Buy |
5,888,766
+131,570
| +2% | +$17.5M | 0.02% | 642 |
|
|
2022
Q2 | $898M | Buy |
5,757,196
+154,546
| +3% | +$24.1M | 0.03% | 597 |
|
|
2022
Q1 | $872M | Buy |
5,602,650
+57,949
| +1% | +$9.02M | 0.02% | 674 |
|
|
2021
Q4 | $706M | Buy |
5,544,701
+66,529
| +1% | +$8.48M | 0.02% | 798 |
|
|
2021
Q3 | $713M | Sell |
5,478,172
-5,307
| -0.1% | -$691K | 0.02% | 779 |
|
|
2021
Q2 | $974M | Buy |
5,483,479
+443,420
| +9% | +$78.8M | 0.02% | 671 |
|
|
2021
Q1 | $828M | Buy |
5,040,059
+162,166
| +3% | +$26.7M | 0.02% | 702 |
|
|
2020
Q4 | $805M | Buy |
4,877,893
+105,160
| +2% | +$17.4M | 0.02% | 664 |
|
|
2020
Q3 | $681M | Sell |
4,772,733
-158,325
| -3% | -$22.6M | 0.02% | 648 |
|
|
2020
Q2 | $544M | Sell |
4,931,058
-219,029
| -4% | -$24.2M | 0.02% | 722 |
|
|
2020
Q1 | $514M | Buy |
5,150,087
+108,869
| +2% | +$10.9M | 0.02% | 658 |
|
|
2019
Q4 | $753M | Buy |
5,041,218
+27,911
| +0.6% | +$4.17M | 0.03% | 651 |
|
|
2019
Q3 | $642M | Buy |
5,013,307
+74,541
| +2% | +$9.55M | 0.02% | 680 |
|
|
2019
Q2 | $704M | Sell |
4,938,766
-130,132
| -3% | -$18.6M | 0.03% | 650 |
|
|
2019
Q1 | $725M | Buy |
5,068,898
+24,032
| +0.5% | +$3.44M | 0.03% | 608 |
|
|
2018
Q4 | $625M | Buy |
5,044,866
+161,882
| +3% | +$20.1M | 0.03% | 614 |
|
|
2018
Q3 | $821M | Buy |
4,882,984
+23,400
| +0.5% | +$3.93M | 0.03% | 579 |
|
|
2018
Q2 | $837M | Buy |
4,859,584
+69,854
| +1% | +$12M | 0.04% | 561 |
|
|
2018
Q1 | $723M | Buy |
4,789,730
+21,161
| +0.4% | +$3.2M | 0.03% | 601 |
|
|
2017
Q4 | $642M | Buy |
4,768,569
+32,795
| +0.7% | +$4.42M | 0.03% | 641 |
|
|
2017
Q3 | $693M | Buy |
4,735,774
+58,551
| +1% | +$8.56M | 0.03% | 591 |
|
|
2017
Q2 | $727M | Buy |
4,677,223
+153,908
| +3% | +$23.9M | 0.04% | 556 |
|
|
2017
Q1 | $656M | Buy |
4,523,315
+152,065
| +3% | +$22.1M | 0.03% | 573 |
|
|
2016
Q4 | $477M | Buy |
4,371,250
+81,511
| +2% | +$8.89M | 0.03% | 676 |
|
|
2016
Q3 | $521M | Buy |
4,289,739
+71,831
| +2% | +$8.73M | 0.03% | 616 |
|
|
2016
Q2 | $596M | Buy |
4,217,908
+4,091
| +0.1% | +$578K | 0.04% | 543 |
|
|
2016
Q1 | $550M | Buy |
4,213,817
+99,804
| +2% | +$13M | 0.04% | 553 |
|
|
2015
Q4 | $578M | Buy |
4,114,013
+153,708
| +4% | +$21.6M | 0.04% | 521 |
|
|
2015
Q3 | $526M | Buy |
3,960,305
+85,072
| +2% | +$11.3M | 0.04% | 538 |
|
|
2015
Q2 | $682M | Buy |
3,875,233
+161,717
| +4% | +$28.5M | 0.05% | 462 |
|
|
2015
Q1 | $642M | Buy |
3,713,516
+236,249
| +7% | +$40.8M | 0.04% | 491 |
|
|
2014
Q4 | $569M | Buy |
3,477,267
+208,854
| +6% | +$34.2M | 0.04% | 500 |
|
|
2014
Q3 | $525M | Buy |
3,268,413
+169,487
| +5% | +$27.2M | 0.04% | 496 |
|
|
2014
Q2 | $456M | Sell |
3,098,926
-63,732
| -2% | -$9.37M | 0.04% | 547 |
|
|
2014
Q1 | $439M | Buy |
3,162,658
+281,441
| +10% | +$39M | 0.04% | 538 |
|
|
2013
Q4 | $365M | Buy |
2,881,217
+81,669
| +3% | +$10.3M | 0.03% | 591 |
|
|
2013
Q3 | $257M | Buy |
2,799,548
+185,239
| +7% | +$17M | 0.03% | 706 |
|
|
2013
Q2 | $180M | Buy |
+2,614,309
| New | +$180M | 0.02% | 826 |
|